SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Endologix Sees Q4 Sales $32.5M-35.5M vs $35.51M Est

Endologix (NASDAQ:ELGX) sees Q4 sales of $32.5 million-35.5 million vs $35.51 million estimate.

Benzinga · -

Endologix (NASDAQ:ELGX) sees Q4 sales of $32.5 million-35.5 million vs $35.51 million estimate.